Solventum has appointed former Zimmer Biomet executive Rachel Ellingson as chief strategy and corporate development officer.
Solventum Co. (NYSE:SOLV – Get Free Report) has been assigned an average rating of “Hold” from the eleven brokerages that are currently covering the company, MarketBeat.com reports. One research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback